发明名称 COMPOSITION AND METHOD FOR INHIBITION OF JAK PATHWAY
摘要 <P>PROBLEM TO BE SOLVED: To provide compounds and methods in the treatment of conditions in which inhibition of JAK kinases, particularly JAK3, a family of cytoplasmic protein tyrosine kinases or modulation of the JAK pathway can be therapeutically useful. <P>SOLUTION: A pharmaceutical composition for inhibiting the activity of JAK kinase contains 5-Fluoro-N2-(4-methyl-3-propionylaminosulfonylphenyl)-N4-[4-(prop-2-ynyloxy)phenyl]-2,4-pyrimidinediamine or a solvate or pharmaceutically acceptable salt thereof. <P>COPYRIGHT: (C)2013,JPO&INPIT
申请公布号 JP2012229217(A) 申请公布日期 2012.11.22
申请号 JP20120129760 申请日期 2012.06.07
申请人 RIGEL PHARMACEUTICALS INC 发明人 LI HUI;THOTA SAMBAIAH;CARROLL DAVID;ARGADE ANKUSH;TSO KIN;SRAN ARVINDER;CLOUGH JEFFREY;KEIM HOLGER;BHAMIDIPATI SOMASEKHAR;TAYLOR VANESSA;COOPER ROBIN;SINGH RAJINDER;WONG BRIAN
分类号 C07D239/48;A61K31/505;A61P37/06;A61P43/00 主分类号 C07D239/48
代理机构 代理人
主权项
地址